Study of the Chinese Prescription Weiqi Decoction on Chronic Atrophic Gastritis

The purpose of this study is to evaluate the efficacy and safety of the Chinese prescription Weiqi decoction on Chronic Atrophic Gastritis.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Gastritis Digestive System Diseases Gastritis, Atrophic Gastroenteritis Gastrointestinal Diseases Stomach Diseases

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Longhua hospital

Shanghai, Shanghai Municipality, 200032, China

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Clinical diagnosis of Chronic Atrophic Gastritis
Male of female patients between 18-65 years old
Written informed consent

Exclusion criteria

Combine with malignant pathology on epithelial dysplasia of gastric mucosa
Combine with duodenal ulcer or gastric ulcer
Combined with severe heart, gallbladder, kidney, endocrine system, hemopoietic system or nervous system disease.
Pregnancy or breast feeding women, or unwilling to have contraception.

Treatment and study plan

Weiqi decotion

Drug

Decoction ,two times a day

Primary outcomes

Symptoms and conditions of tongue and pulse,the gastroscopy and pathological change

Time frame: 12 weeks

Secondary outcomes

Indicates of liver and renal function

Time frame: 12 weeks

Sponsors and collaborators

Lead sponsor

Shanghai University of Traditional Chinese Medicine

Other

Registry information

Important dates

Study start: 2009
Primary completion: 2012
Study completion: 2012
First posted: Jun 15, 2009
Registry last updated: Apr 19, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed